GOTHENBURG, Sweden, July 1, 2025 — Vitrolife AB (publ) has today finalized a new EUR 300 million loan agreement, which includes both a term loan and a revolving credit facility. The term loan portion is designated for refinancing existing debt, while the revolving credit facility will be available for general corporate purposes.
This loan agreement is supported by leading Nordic banks; Nordea and SEB have renewed their commitments, and AB Svensk Exportkredit has joined as a new lender. This collaboration underscores the Vitrolife Group’s robust credit profile and its emphasis on export activities. The agreement has a three-year tenor, with options for two additional one-year extensions.
“We are grateful for the support from both our existing and new banking partners in connection with this refinancing,” stated Bronwyn Brophy O’Connor, CEO of the Vitrolife Group. “This successful transaction reinforces the confidence placed in the Vitrolife Group.”
Gothenburg, 1 July 2025
VITROLIFE AB (publ)
Bronwyn Brophy O’Connor, CEO
Contact:
Amelie Wilson, Investor Relations, External Corporate Communications and Executive Support
This press release is a translation of the original Swedish version. In the event of any discrepancy, the Swedish wording shall prevail.
Information provided by Cision
Downloadable files include:
|
|
Vitrolife Group completes refinancing facility backed by leading Nordic Banks |
Source: Vitrolife AB (publ)